Antiproliferative Effect of Aaptamine on Human Chronic Myeloid Leukemia K562 Cells

被引:28
作者
Jin, Meihua [1 ,2 ]
Zhao, Wennan [1 ,2 ]
Zhang, Yanwen [1 ,2 ]
Kobayashi, Motomasa [3 ]
Duan, Hongquan [1 ,2 ]
Kong, Dexin [1 ,2 ]
机构
[1] Tianjin Med Univ, Sch Pharmaceut Sci, Tianjin Key Lab Technol Enabling Dev Clin Therape, Tianjin 300070, Peoples R China
[2] Tianjin Med Univ, Res Ctr Basic Med Sci, Tianjin 300070, Peoples R China
[3] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan
关键词
aaptamine; K562; cells; G2/M arrest; p21; SESQUITERPENE AMINOQUINONE; ERYTHROID-DIFFERENTIATION; MARINE SPONGE; BCR-ABL; SMENOSPONGINE; RESISTANCE; MECHANISMS; MUTATIONS;
D O I
10.3390/ijms12117352
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We previously isolated aaptamine, a benzonaphthyridine alkaloid, from marine sponge Aaptos suberitoids. In this study, we investigated the anti-proliferative effect of aaptamine on chronic myeloid leukemia (CML) K562 cells. Aaptamine inhibited growth of K562 with a GI50 as 10 mu M, and arrested cell cycle at G2/M phase. Western blot analysis indicated that aaptamine induced p21 expression in K562 cells. Moreover, p21 promoter was activated by aaptamine treatment in p21 transfected K562 cells. Since K562 is p53 negative, aaptamine was demonstrated to be a p53-independent p21 inducer in CML cells.
引用
收藏
页码:7352 / 7359
页数:8
相关论文
共 16 条
[1]   Aaptamine, a spongean alkaloid, activates p21 promoter in a p53-independent manner [J].
Aoki, S ;
Kong, DX ;
Suna, H ;
Sowa, Y ;
Sakai, T ;
Setiawan, A ;
Kobayashi, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 342 (01) :101-106
[2]   Sesquiterpene aminoquinones, from a marine sponge, induce erythroid differentiation in human chronic myelogenous leukemia, K562 cells [J].
Aoki, S ;
Kong, D ;
Matsui, K ;
Rachmat, R ;
Kobayashi, M .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2004, 52 (08) :935-937
[3]  
Aoki S, 2004, ANTICANCER RES, V24, P2325
[4]   Smenospongine, a spongean sesquiterpene aminoquinone, induces erythroid differentiation in K562 cells [J].
Aoki, S ;
Kong, D ;
Matsui, K ;
Kobayashi, M .
ANTI-CANCER DRUGS, 2004, 15 (04) :363-369
[5]   Mechanisms of autoinhibition and STI-571/imatinib resistance revealed by mutagenesis of BCR-ABL [J].
Azam, M ;
Latek, RR ;
Daley, GQ .
CELL, 2003, 112 (06) :831-843
[6]   Development of Yondelis® (trabectedin, ET-743). A semisynthetic process solves the supply problem [J].
Cuevas, Carmen ;
Francesch, Andres .
NATURAL PRODUCT REPORTS, 2009, 26 (03) :322-337
[7]   A CELLULAR ONCOGENE IS TRANSLOCATED TO THE PHILADELPHIA-CHROMOSOME IN CHRONIC MYELOCYTIC-LEUKEMIA [J].
DEKLEIN, A ;
VANKESSEL, AG ;
GROSVELD, G ;
BARTRAM, CR ;
HAGEMEIJER, A ;
BOOTSMA, D ;
SPURR, NK ;
HEISTERKAMP, N ;
GROFFEN, J ;
STEPHENSON, JR .
NATURE, 1982, 300 (5894) :765-767
[8]   P53 MUTATIONS IN HUMAN CANCERS [J].
HOLLSTEIN, M ;
SIDRANSKY, D ;
VOGELSTEIN, B ;
HARRIS, CC .
SCIENCE, 1991, 253 (5015) :49-53
[9]   Smenospongine, a sesquiterpene aminoquinone from a marine sponge, induces G1 arrest or apoptosis in different leukemia cells [J].
Kong, Dexin ;
Aoki, Shunji ;
Sowa, Yoshihiro ;
Sakai, Toshiyuki ;
Kobayashi, Motomasa .
MARINE DRUGS, 2008, 6 (03) :480-488
[10]   Antiproliferative and Antiangiogenic Activities of Smenospongine, a Marine Sponge Sesquiterpene Aminoquinone [J].
Kong, Dexin ;
Yamori, Takao ;
Kobayashi, Motomasa ;
Duan, Hongquan .
MARINE DRUGS, 2011, 9 (02) :154-161